Stay updated with breaking news from Vallon Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ROCKVILLE, MD, Jan. 04, 2023 -- MacroGenics, Inc. , a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of... | January 4, 2023
The FDA approved an expansion in the label for Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) immunotherapy Libtayo for treating patients with advanced basal cell carcinoma previously treated with a hedgehog pathway inhibitor, HHI, or for whom an HHI is not appropriate. Full approval was granted for patients with locally advanced BCC and accelerated approval was granted for patients with metastatic BCC. Moderna Strikes Vaccine Supply Agreements With Taiwan and Columbia Moderna Inc (NASDAQ: MRNA) announced two supply agreements for its COVID-19 Vaccine - one with ...